Please provide your email address to receive an email when new articles are posted on . Both vaccinated and post-infection patients with psoriasis were included in this study. Researchers found that ...

Patients with atopic dermatitis, psoriasis, or vitiligo who use immunosuppressants or were vaccinated against COVID-19 are not at an increased risk of developing COVID-19. Progressive disease activity ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. COVID-19 has had an effect on how we care ...

The course of COVID-19 in patients with psoriasis was characterized and factors associated with hospitalization were identified in an international case study. The use of biologic agents among ...

Biologics and oral small molecules for treating PsO show a favorable safety profile overall, particularly when it comes to infection risk.